Clinical Trials · NCT02020499
Predictive Factors Study
- Phase
- N/A
- Recruitment status
- Terminated
- Sponsor
- Ipsen
- Enrollment
- 5
- Start date
- Aug 2014
- Locations
- 6 sites, Australia
- Primary endpoint
- Change in Growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels from baseline